Thursday, 5 November 2026European Markets

VERALLIA And TFF GROUP Have A High Dividend Yield And Return On Equity In The Packaging & Containers Industry.

Loading stream...

(vianews) - verallia (vrla.pa) is among this list of stock assets with the highest dividend rate and return on equity on the packaging & containers industry.

financial asset price forward dividend yield return on equity
verallia (vrla.pa) €30.84 4.57% 44.03%
tff group (tff.pa) €42.30 1.43% 12.23%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. verallia (vrla.pa)

4.57% forward dividend yield and 44.03% return on equity

verallia société anonyme produces and sells glass packaging products for beverages and food industry worldwide. it also provides bottles for still and sparkling wines, spirits, beers, soft drinks, and oils. the company offers jars for baby food, dairy products, jams, honey, spreads, condiments, sauces, and preserves. verallia société anonyme was founded in 1827 and is based in courbevoie, france.

earnings per share

as for profitability, verallia has a trailing twelve months eps of €4.08.

pe ratio

verallia has a trailing twelve months price to earnings ratio of 7.56. meaning, the purchaser of the share is investing €7.56 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 44.03%.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, verallia's stock is considered to be oversold (<=20).

volume

today's last reported volume for verallia is 29927 which is 80.59% below its average volume of 154208.

more news about verallia.

2. tff group (tff.pa)

1.43% forward dividend yield and 12.23% return on equity

tff group manufactures and distributes barrels and wood products for the aging of wines, spirits, and alcohols in france, rest of europe, oceania and south africa, the united states, and internationally. the company also offers staves, cooperages, casks, wood and oenological products, and stainless steel containers. it primarily serves wine, whisky, and bourbon markets. the company was formerly known as tonnellerie françois frères. tff group was founded in 1910 and is based in saint-romain, france.

earnings per share

as for profitability, tff group has a trailing twelve months eps of €2.44.

pe ratio

tff group has a trailing twelve months price to earnings ratio of 17.34. meaning, the purchaser of the share is investing €17.34 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.23%.

moving average

tff group's value is under its 50-day moving average of €42.31 and higher than its 200-day moving average of €41.26.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, tff group's stock is considered to be overbought (>=80).

volatility

tff group's last week, last month's, and last quarter's current intraday variation average was a positive 0.48%, a negative 0.09%, and a positive 1.08%.

tff group's highest amplitude of average volatility was 1.44% (last week), 1.15% (last month), and 1.08% (last quarter).

dividend yield

as maintained by morningstar, inc., the next dividend payment is on nov 8, 2023, the estimated forward annual dividend rate is 0.6 and the estimated forward annual dividend yield is 1.43%.

more news about tff group.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,549 source documents archived
Query this data → isubstrate.com